Replies to post #92101 on China Growth Stocks

[BiotechValues]

SUTR- looks OK, although net income was down 17% yoy.
But on the more positive side, they have a real stock buyback in place, they've got a new facility coming online, and seem to be increasing transparency/return investor confidence- all good things.

But I also think this underscores the value of LGHS, which has 1/3 the market cap of SUTR, and 4x the eps.

..................................LGHS.........SUTR
Market Cap:---------------$11.0M--------------32.3M
Price/Earnings:-----------.92X----------------2.7
Revenue (TTM):-----------$617M--------------$532M
EPS (TTM):----------------$1.20--------------.30